Laparoscopic transdiaphragmatic pericardial fenestration in palliative care: how I do it

Abstract

Background

The optimal therapeutic strategy for drainage of malignant pericardial effusion is not yet determined. Several techniques are described, with different benefits and disadvantages. The literature suggests that surgical drainage of pericardial effusions has less effusion recurrence; however, randomized controlled trials are not available.

Due to the nature of the disease, quality of life should always be considered while making treatment decisions.

Methods

A retrospective analysis of all consecutive patients from November 2016 until June 2019 of our institution in the Netherlands was performed. All patients underwent laparoscopic pericardial fenestration after echocardiography and request for operative treatment by the cardiologist. The same operation technique was performed in every case.

Results

Four out of five of our patients needed pericardial fenestration because of oncological diseases.

No hemodynamically instability was noted during this fast technique, achieving direct relief of symptoms. No treatment-related morbidity or mortality, nor the need for re-intervention was encountered. We compared the outcome of our five patients with the existing evidence in the literature.

Conclusions

In this article, we highlight the laparoscopic transdiaphragmatic pericardial fenestration as a treatment of preference in a non-acute palliative setting. This laparoscopic approach is safe, and can be a valuable alternative among the other well-known approaches.

Keywords:

• Pericardiocentesis
• fenestration
• laparoscopic
• palliation
• oncological care

Acknowledgement

The authors thank ETZ Hospital Tilburg, The Netherlands for providing the patient data.

Ethical approval

This paper is in accordance with the ethical standards (institutional and national).

Human rights and informed consent

The study was conducted according to medical and ethical regulations in the Netherlands.

Disclosure statement

Drs. F. De Haes, D.D.E. Zimmerman, M. Özmen, K.W.A. Göttgens and B.S. Langenhoff have no conflicts of interest or financial ties to disclose.